326 related articles for article (PubMed ID: 20926694)
1. Porcine reproductive and respiratory syndrome virus infection at the time of porcine circovirus type 2 vaccination has no impact on vaccine efficacy.
Sinha A; Shen HG; Schalk S; Beach NM; Huang YW; Halbur PG; Meng XJ; Opriessnig T
Clin Vaccine Immunol; 2010 Dec; 17(12):1940-5. PubMed ID: 20926694
[TBL] [Abstract][Full Text] [Related]
2. An experimental live chimeric porcine circovirus 1-2a vaccine decreases porcine circovirus 2b viremia when administered intramuscularly or orally in a porcine circovirus 2b and porcine reproductive and respiratory syndrome virus dual-challenge model.
Opriessnig T; Gomes-Neto JC; Hemann M; Shen HG; Beach NM; Huang Y; Halbur PG; Meng XJ
Microbiol Immunol; 2011 Dec; 55(12):863-73. PubMed ID: 21951266
[TBL] [Abstract][Full Text] [Related]
3. Comparative effects of vaccination against porcine circovirus type 2 (PCV2) and porcine reproductive and respiratory syndrome virus (PRRSV) in a PCV2-PRRSV challenge model.
Park C; Oh Y; Seo HW; Han K; Chae C
Clin Vaccine Immunol; 2013 Mar; 20(3):369-76. PubMed ID: 23302743
[TBL] [Abstract][Full Text] [Related]
4. Vaccination with a Porcine Reproductive and Respiratory Syndrome (PRRS) Modified Live Virus Vaccine Followed by Challenge with PRRS Virus and Porcine Circovirus Type 2 (PCV2) Protects against PRRS but Enhances PCV2 Replication and Pathogenesis Compared to Results for Nonvaccinated Cochallenged Controls.
Niederwerder MC; Bawa B; Serão NV; Trible BR; Kerrigan MA; Lunney JK; Dekkers JC; Rowland RR
Clin Vaccine Immunol; 2015 Dec; 22(12):1244-54. PubMed ID: 26446422
[TBL] [Abstract][Full Text] [Related]
5. Effect of porcine circovirus type 2 (PCV2) vaccination on porcine reproductive and respiratory syndrome virus (PRRSV) and PCV2 coinfection.
Opriessnig T; Madson DM; Prickett JR; Kuhar D; Lunney JK; Elsener J; Halbur PG
Vet Microbiol; 2008 Sep; 131(1-2):103-14. PubMed ID: 18430525
[TBL] [Abstract][Full Text] [Related]
6. A live-attenuated chimeric porcine circovirus type 2 (PCV2) vaccine is transmitted to contact pigs but is not upregulated by concurrent infection with porcine parvovirus (PPV) and porcine reproductive and respiratory syndrome virus (PRRSV) and is efficacious in a PCV2b-PRRSV-PPV challenge model.
Opriessnig T; Shen HG; Pal N; Ramamoorthy S; Huang YW; Lager KM; Beach NM; Halbur PG; Meng XJ
Clin Vaccine Immunol; 2011 Aug; 18(8):1261-8. PubMed ID: 21653745
[TBL] [Abstract][Full Text] [Related]
7. Porcine circovirus type 2 infection decreases the efficacy of a modified live porcine reproductive and respiratory syndrome virus vaccine.
Opriessnig T; McKeown NE; Harmon KL; Meng XJ; Halbur PG
Clin Vaccine Immunol; 2006 Aug; 13(8):923-9. PubMed ID: 16893993
[TBL] [Abstract][Full Text] [Related]
8. Protective efficacy of a virus-vectored multi-component vaccine against porcine reproductive and respiratory syndrome virus, porcine circovirus type 2 and swine influenza virus.
Tian D; Sooryanarain H; Matzinger SR; Gauger PC; Karuppannan AK; Elankumaran S; Opriessnig T; Meng XJ
J Gen Virol; 2017 Dec; 98(12):3026-3036. PubMed ID: 29091579
[TBL] [Abstract][Full Text] [Related]
9. Comparison of four commercial one-dose porcine circovirus type 2 (PCV2) vaccines administered to pigs challenged with PCV2 and porcine reproductive and respiratory syndrome virus at 17 weeks postvaccination to control porcine respiratory disease complex under Korean field conditions.
Park C; Seo HW; Han K; Chae C
Clin Vaccine Immunol; 2014 Mar; 21(3):399-406. PubMed ID: 24403524
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of the efficacy of a trivalent vaccine mixture against a triple challenge with Mycoplasma hyopneumoniae, PCV2, and PRRSV and the efficacy comparison of the respective monovalent vaccines against a single challenge.
Oh T; Park KH; Yang S; Jeong J; Kang I; Park C; Chae C
BMC Vet Res; 2019 Oct; 15(1):342. PubMed ID: 31619295
[TBL] [Abstract][Full Text] [Related]
11. Concurrent vaccinations against PCV2 and PRRSV: study on the specific immunity and clinical protection in naturally infected pigs.
Martelli P; Ardigò P; Ferrari L; Morganti M; De Angelis E; Bonilauri P; Luppi A; Guazzetti S; Caleffi A; Borghetti P
Vet Microbiol; 2013 Mar; 162(2-4):558-571. PubMed ID: 23206413
[TBL] [Abstract][Full Text] [Related]
12. A PCV2 vaccine based on genotype 2b is more effective than a 2a-based vaccine to protect against PCV2b or combined PCV2a/2b viremia in pigs with concurrent PCV2, PRRSV and PPV infection.
Opriessnig T; O'Neill K; Gerber PF; de Castro AM; Gimenéz-Lirola LG; Beach NM; Zhou L; Meng XJ; Wang C; Halbur PG
Vaccine; 2013 Jan; 31(3):487-94. PubMed ID: 23174198
[TBL] [Abstract][Full Text] [Related]
13. One dose of a porcine circovirus 2 subunit vaccine induces humoral and cell-mediated immunity and protects against porcine circovirus-associated disease under field conditions.
Martelli P; Ferrari L; Morganti M; De Angelis E; Bonilauri P; Guazzetti S; Caleffi A; Borghetti P
Vet Microbiol; 2011 May; 149(3-4):339-51. PubMed ID: 21216540
[TBL] [Abstract][Full Text] [Related]
14. Commercial PCV2a-based vaccines are effective in protecting naturally PCV2b-infected finisher pigs against experimental challenge with a 2012 mutant PCV2.
Opriessnig T; Gerber PF; Xiao CT; Halbur PG; Matzinger SR; Meng XJ
Vaccine; 2014 Jul; 32(34):4342-8. PubMed ID: 24929119
[TBL] [Abstract][Full Text] [Related]
15. Effect of an interferon-stimulated response element (ISRE) mutant of porcine circovirus type 2 (PCV2) on PCV2-induced pathological lesions in a porcine reproductive and respiratory syndrome virus (PRRSV) co-infection model.
Ramamoorthy S; Opriessnig T; Pal N; Huang FF; Meng XJ
Vet Microbiol; 2011 Jan; 147(1-2):49-58. PubMed ID: 20637549
[TBL] [Abstract][Full Text] [Related]
16. Comparison of sow and/or piglet vaccination of 3 commercial porcine circovirus type 2 (PCV2) single-dose vaccines on pigs under experimental PCV2 challenge.
Oh Y; Seo HW; Park C; Chae C
Vet Microbiol; 2014 Aug; 172(3-4):371-80. PubMed ID: 24970364
[TBL] [Abstract][Full Text] [Related]
17. Comparison of 3 vaccination strategies against porcine reproductive and respiratory syndrome virus,
Jeong J; Kang I; Kim S; Park KH; Park C; Chae C
Can J Vet Res; 2018 Jan; 82(1):39-47. PubMed ID: 29382967
[TBL] [Abstract][Full Text] [Related]
18. Comparison of commercial and experimental porcine circovirus type 2 (PCV2) vaccines using a triple challenge with PCV2, porcine reproductive and respiratory syndrome virus (PRRSV), and porcine parvovirus (PPV).
Shen HG; Beach NM; Huang YW; Halbur PG; Meng XJ; Opriessnig T
Vaccine; 2010 Aug; 28(37):5960-6. PubMed ID: 20637768
[TBL] [Abstract][Full Text] [Related]
19. Gut microbiome associations with outcome following co-infection with porcine reproductive and respiratory syndrome virus (PRRSV) and porcine circovirus type 2 (PCV2) in pigs immunized with a PRRS modified live virus vaccine.
Constance LA; Thissen JB; Jaing CJ; McLoughlin KS; Rowland RRR; Serão NVL; Cino-Ozuna AG; Niederwerder MC
Vet Microbiol; 2021 Mar; 254():109018. PubMed ID: 33639341
[TBL] [Abstract][Full Text] [Related]
20. Impact of porcine reproductive and respiratory syndrome virus and porcine circovirus-2 infection on the potency of the classical swine fever vaccine (LOM strain).
Lim SI; Jeoung HY; Kim B; Song JY; Kim J; Kim HY; Cho IS; Woo GH; Lee JB; An DJ
Vet Microbiol; 2016 Sep; 193():36-41. PubMed ID: 27599928
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
